Howell A - Search Results

1

Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.

Roberts E, van Veen EM, Byers H, Barnett-Griness O, Gronich N, Lejbkowicz F, Pinchev M, Smith MJ, Howell A, Newman WG, Woodward ER, Harkness EF, Brentnall AR, Cuzick J, Rennert G, Howell SJ, Evans DG. Roberts E, et al. Among authors: howell sj, howell a. Genet Med. 2023 Sep;25(9):100846. doi: 10.1016/j.gim.2023.100846. Epub 2023 Apr 12. Genet Med. 2023. PMID: 37061873 Free article.

2

New approaches to the endocrine prevention and treatment of breast cancer.

Howell A, Howell SJ, Evans DG. Howell A, et al. Among authors: howell sj. Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S39-44. doi: 10.1007/s00280-003-0645-5. Epub 2003 Jun 18. Cancer Chemother Pharmacol. 2003. PMID: 12819938 Review.

3

Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?

Evans DG, Howell A. Evans DG, et al. Among authors: howell a. Breast Cancer Res. 2004;6(1):E7. doi: 10.1186/bcr748. Breast Cancer Res. 2004. PMID: 14680492 Free PMC article.

4

The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.

Howell SJ, Johnston SR, Howell A. Howell SJ, et al. Among authors: howell a. Best Pract Res Clin Endocrinol Metab. 2004 Mar;18(1):47-66. doi: 10.1016/j.beem.2003.08.002. Best Pract Res Clin Endocrinol Metab. 2004. PMID: 14687597 Review.

5

Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.

Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A. Fallowfield L, et al. Among authors: howell a. J Clin Oncol. 2004 Nov 1;22(21):4261-71. doi: 10.1200/JCO.2004.08.029. J Clin Oncol. 2004. PMID: 15514369

6

Vascular effects of aromatase inhibitors: data from clinical trials.

Howell A, Cuzick J. Howell A, et al. J Steroid Biochem Mol Biol. 2005 May;95(1-5):143-9. doi: 10.1016/j.jsbmb.2005.04.005. J Steroid Biochem Mol Biol. 2005. PMID: 15936188

7

Early stopping of clinical trials.

Cuzick J, Howell A, Forbes J. Cuzick J, et al. Among authors: howell a. Breast Cancer Res. 2005;7(5):181-3. doi: 10.1186/bcr1280. Epub 2005 Jun 21. Breast Cancer Res. 2005. PMID: 16168134 Free PMC article.

8

Re: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Cuzick J, Forbes JF, Howell A. Cuzick J, et al. Among authors: howell a. J Natl Cancer Inst. 2006 May 3;98(9):643; author reply 643-4. doi: 10.1093/jnci/djj167. J Natl Cancer Inst. 2006. PMID: 16670391 No abstract available.

9

Predicting compliance in a breast cancer prevention trial.

Maurice A, Howell A, Evans DG, O'Neil AC, Scobie S. Maurice A, et al. Among authors: howell a. Breast J. 2006 Sep-Oct;12(5):446-50. doi: 10.1111/j.1075-122X.2006.00295.x. Breast J. 2006. PMID: 16958964 Clinical Trial.

10

Estrogen deprivation for breast cancer prevention.

Howell A, Clarke RB, Evans G, Bundred N, Cuzick J, Santen R, Allred C. Howell A, et al. Recent Results Cancer Res. 2007;174:151-67. doi: 10.1007/978-3-540-37696-5_13. Recent Results Cancer Res. 2007. PMID: 17302193 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,247 results

Search Page